Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Medivolve Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.03 |
52 Week High | US$0.13 |
52 Week Low | US$0.015 |
Beta | 2.78 |
1 Month Change | 50.00% |
3 Month Change | 50.00% |
1 Year Change | -73.91% |
3 Year Change | n/a |
5 Year Change | -98.46% |
Change since IPO | -99.97% |
Recent News & Updates
Recent updates
Shareholder Returns
MEDV | CA Healthcare | CA Market | |
---|---|---|---|
7D | 20.0% | -1.4% | 0.4% |
1Y | -73.9% | 2.6% | 9.3% |
Return vs Industry: MEDV underperformed the Canadian Healthcare industry which returned -2.7% over the past year.
Return vs Market: MEDV underperformed the Canadian Market which returned 3.6% over the past year.
Price Volatility
MEDV volatility | |
---|---|
MEDV Average Weekly Movement | 45.4% |
Healthcare Industry Average Movement | 4.7% |
Market Average Movement | 8.6% |
10% most volatile stocks in CA Market | 18.6% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: MEDV's share price has been volatile over the past 3 months.
Volatility Over Time: MEDV's weekly volatility has increased from 29% to 45% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 25 | David Preiner | https://www.medivolve.ca |
Medivolve Inc. is a principal investment firm. It prefers to invest in healthcare technology, industrials, information technology. Medivolve Inc., formerly known as QuestCap Inc, was founded in 2005 and is based in Toronto, Canada.
Medivolve Inc. Fundamentals Summary
MEDV fundamental statistics | |
---|---|
Market cap | CA$729.65k |
Earnings (TTM) | -CA$9.25m |
Revenue (TTM) | CA$36.58m |
0.0x
P/S Ratio-0.1x
P/E RatioIs MEDV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MEDV income statement (TTM) | |
---|---|
Revenue | CA$36.58m |
Cost of Revenue | CA$22.33m |
Gross Profit | CA$14.26m |
Other Expenses | CA$23.51m |
Earnings | -CA$9.25m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.34 |
Gross Margin | 38.97% |
Net Profit Margin | -25.28% |
Debt/Equity Ratio | -22.0% |
How did MEDV perform over the long term?
See historical performance and comparison